These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 34907988)

  • 1. Downstaging in Advanced Rectal Cancers: A Propensity-Matched Comparison Between Short-Course Radiotherapy Followed by Chemotherapy and Long-Course Chemoradiotherapy.
    Kammar PS; Garach NR; Masillamany S; de'Souza A; Ostwal V; Saklani AP
    Dis Colon Rectum; 2022 Oct; 65(10):1215-1223. PubMed ID: 34907988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
    Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
    Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bowel Functional Outcomes After Long-Course or Short-Course Radiation for Advanced Rectal Cancers: A Propensity-Matched Analysis.
    Kazi M; Jajoo B; Kapadia R; Dohale S; Bhuta P; Desouza A; Saklani A
    Dis Colon Rectum; 2022 Dec; 65(12):1494-1502. PubMed ID: 36382840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
    Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
    Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
    Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
    Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
    Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
    Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
    Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Positive Circumferential Resection Margin in Rectal Cancer: A Current Audit of the National Cancer Database.
    Simon HL; de Paula TR; Profeta da Luz MM; Kiran RP; Keller DS
    Dis Colon Rectum; 2021 Sep; 64(9):1096-1105. PubMed ID: 33951688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
    Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer.
    Xu Z; Valente MA; Sklow B; Liska D; Gorgun E; Kessler H; Rosen DR; Steele SR
    Dis Colon Rectum; 2023 Jul; 66(7):1022-1028. PubMed ID: 36538720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI at Restaging After Neoadjuvant Therapy for Rectal Cancer Overestimates Circumferential Resection Margin Proximity as Determined by Comparison With Whole-Mount Pathology.
    Yuval JB; Thompson HM; Firat C; Verheij FS; Widmar M; Wei IH; Pappou E; Smith JJ; Weiser MR; Paty PB; Nash GM; Shia J; Gollub MJ; Garcia-Aguilar J
    Dis Colon Rectum; 2022 Apr; 65(4):489-496. PubMed ID: 34803147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of the Circumferential Resection Margin After Curative Surgery for Rectal Cancer: A Multicenter Propensity Score-Matched Analysis.
    Galvez A; Biondo S; Trenti L; Espin E; Kraft M; Farres R; Codina-Cazador A; Flor B; Garcia-Granero E; Enriquez-Navascues JM; Borda-Arrizabalaga N; Kreisler E
    Dis Colon Rectum; 2023 Jul; 66(7):887-897. PubMed ID: 35348529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
    Park SY; Lee SM; Park JS; Kim HJ; Choi GS
    Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circumferential Resection Margin After Laparoscopic and Open Rectal Resection: A Nationwide Propensity Score Matched Cohort Study.
    Klein MF; Vogelsang RP; Gögenur I
    Dis Colon Rectum; 2019 Oct; 62(10):1177-1185. PubMed ID: 31490826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
    Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
    Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiologic Factors and Areas of Local Recurrence in Locally Advanced Lower Rectal Cancer After Lateral Pelvic Lymph Node Dissection.
    Shiraishi T; Sasaki T; Tsukada Y; Ikeda K; Nishizawa Y; Ito M
    Dis Colon Rectum; 2021 Dec; 64(12):1479-1487. PubMed ID: 34657076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
    You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
    Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
    Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
    Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.